Related Experiment Videos
Stereotactic Percutaneous Breast Biopsy: A Comparative Analysis Between Surgeon and Radiologist
Cary L. Gentry1, C. Alan Henry
1Carilion Health Systems, Roanoke, Virginia.
The Breast Journal
|May 12, 2001
Summary
Stereotactic percutaneous breast biopsy is an accurate and cost-effective method for diagnosing nonpalpable breast abnormalities. Both surgeons and radiologists achieve similar accuracy, saving patients $1500-$2500 compared to excisional biopsy.
Area of Science:
- Radiology
- Surgical Oncology
- Breast Imaging
Background:
- Nonpalpable breast abnormalities require accurate diagnostic methods.
- Minimally invasive biopsy techniques are increasingly important in breast diagnostics.
- Comparing procedural outcomes and costs is crucial for healthcare providers.
Purpose of the Study:
- To analyze stereotactic percutaneous breast biopsy (SCBx) for nonpalpable breast abnormalities.
- To compare the diagnostic accuracy between radiologists and surgeons performing SCBx.
- To estimate the cost-effectiveness of SCBx versus needle localization excisional biopsy (NleBx).
Main Methods:
- Retrospective analysis of 193 patients undergoing SCBx (Dec 1995-Feb 1997).
- Comparison with 106 patients who underwent NleBx during the same period.
- Statistical analysis of radiologist vs. surgeon performance and cost comparison.
Main Results:
- SCBx by either surgeons or radiologists is accurate for nonpalpable breast lesions.
- SCBx saves approximately $1500-$2500 per patient compared to NleBx.
- Similar accuracy was achieved by adequately trained surgeons and radiologists.
Conclusions:
- Stereotactic percutaneous breast biopsy is an accurate and cost-effective diagnostic tool.
- Both surgeons and radiologists can perform SCBx with comparable accuracy.
- SCBx offers significant cost savings for evaluating nonpalpable breast abnormalities.